From the Research
Transcatheter Aortic Valve Implantation (TAVI) for Asymptomatic Patients
- The provided studies primarily focus on TAVI for symptomatic patients with severe aortic stenosis, with no direct mention of asymptomatic patients 1, 2, 3, 4, 5.
- The studies discuss the indications, techniques, complications, and management of TAVI, but do not explicitly address the feasibility of TAVI for asymptomatic patients with severe aortic stenosis.
- The decision-making process for TAVI is emphasized to be multidisciplinary, involving a heart team that considers individual patient factors, including clinical and anatomical factors, as well as lifetime management considerations 1.
- While the studies highlight the evolution and refinement of TAVI techniques, they do not provide evidence on the use of TAVI for asymptomatic patients with severe aortic stenosis 2, 3, 4, 5.
Current State of TAVI Research
- The majority of the studies focus on symptomatic patients, with TAVI being established as a safe and efficacious treatment for this population 2, 3, 5.
- The studies discuss various access routes and approaches for TAVI, including transfemoral, transcarotid, axillary/subclavian, transapical, and transaortic routes, but do not address the use of TAVI for asymptomatic patients 2, 5.
- The importance of a multidisciplinary approach and continuous research in the field of TAVI is emphasized, but the specific question of TAVI for asymptomatic patients remains unaddressed 1, 3, 4, 5.